Gossamer Bio Stock Price on November 8, 2024
| GOSS Stock | USD 0.70 0.04 6.06% |
Below is the normalized historical share price chart for Gossamer Bio extending back to February 08, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Gossamer Bio stands at 0.70, as last reported on the 25th of November, with the highest price reaching 0.71 and the lowest price hitting 0.67 during the day.
If you're considering investing in Gossamer Stock, it is important to understand the factors that can impact its price. Gossamer Bio holds Efficiency (Sharpe) Ratio of -0.1, which attests that the entity had a -0.1% return per unit of risk over the last 3 months. Gossamer Bio exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Gossamer Bio's Risk Adjusted Performance of (0.06), market risk adjusted performance of (0.53), and Standard Deviation of 3.39 to validate the risk estimate we provide.
At this time, Gossamer Bio's Total Stockholder Equity is comparatively stable compared to the past year. Common Stock Shares Outstanding is likely to gain to about 160.3 M in 2024, whereas Sale Purchase Of Stock is likely to drop slightly above 421.8 K in 2024. . At this time, Gossamer Bio's Price Book Value Ratio is comparatively stable compared to the past year. Price Earnings To Growth Ratio is likely to gain to 0.01 in 2024, despite the fact that Price To Operating Cash Flows Ratio is likely to grow to (0.83). Gossamer Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 8th of February 2019 | 200 Day MA 0.9347 | 50 Day MA 0.9116 | Beta 1.96 |
Gossamer |
Sharpe Ratio = -0.1032
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GOSS |
Estimated Market Risk
| 3.42 actual daily | 30 70% of assets are more volatile |
Expected Return
| -0.35 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Gossamer Bio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Gossamer Bio by adding Gossamer Bio to a well-diversified portfolio.
Price Book 2.9117 | Enterprise Value Ebitda (0.39) | Price Sales 1.4966 | Shares Float 188 M | Wall Street Target Price 6.7188 |
Related Headline
Stoke Therapeutics Headline on 8th of November 2024
CV Sciences and Stoke Therapeutics Head to Head Review by thelincolnianonline.com
CV Sciences and Stoke Therapeutics are both small-cap medical companies, but which is the superior stock We will compare the two companies based on the strength of their dividends, risk, institutional ownership, earnings, analyst recommendations, valuation and profitability. Earnings and Valuation This table compares CV
Gossamer Bio Valuation on November 8, 2024
It is possible to determine the worth of Gossamer Bio on a given historical date. On November 8, 2024 Gossamer was worth 0.87 at the beginning of the trading date compared to the closed value of 0.88. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Gossamer Bio stock. Still, in general, we apply an absolute valuation method to find Gossamer Bio's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Gossamer Bio where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Gossamer Bio's related companies.
| Open | High | Low | Close | Volume | |
| 0.89 | 0.92 | 0.88 | 0.89 | 518,968 | |
11/08/2024 | 0.87 | 0.90 | 0.85 | 0.88 | 981,401 |
| 0.87 | 0.89 | 0.85 | 0.86 | 821,835 |
| Backtest Gossamer Bio | | | Gossamer Bio History | | | Gossamer Bio Valuation | Previous | Next |
Gossamer Bio Trading Date Momentum on November 8, 2024
| On November 11 2024 Gossamer Bio was traded for 0.86 at the closing time. The top price for the day was 0.89 and the lowest listed price was 0.85 . The trading volume for the day was 821.8 K. The trading history from November 11, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 2.27% . The overall trading delta against the current closing price is 14.77% . |
Gossamer Bio Fundamentals Correlations and Trends
By evaluating Gossamer Bio's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Gossamer Bio's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Gossamer financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Gossamer Bio Stock history
Gossamer Bio investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Gossamer is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Gossamer Bio will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Gossamer Bio stock prices may prove useful in developing a viable investing in Gossamer Bio
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 152.6 M | 160.3 M | |
| Net Loss | -206.4 M | -216.8 M |
Gossamer Bio Quarterly Net Working Capital |
|
Gossamer Bio Stock Technical Analysis
Gossamer Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Gossamer Bio Period Price Range
Low | November 25, 2024
| High |
0.00 | 0.00 |
Gossamer Bio cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Gossamer Bio November 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Gossamer Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Gossamer Bio shares will generate the highest return on investment. By undertsting and applying Gossamer Bio stock market strength indicators, traders can identify Gossamer Bio entry and exit signals to maximize returns
Gossamer Bio Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Gossamer Bio's price direction in advance. Along with the technical and fundamental analysis of Gossamer Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Gossamer to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.39) | |||
| Total Risk Alpha | (0.85) | |||
| Treynor Ratio | (0.54) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Gossamer Stock Analysis
When running Gossamer Bio's price analysis, check to measure Gossamer Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gossamer Bio is operating at the current time. Most of Gossamer Bio's value examination focuses on studying past and present price action to predict the probability of Gossamer Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gossamer Bio's price. Additionally, you may evaluate how the addition of Gossamer Bio to your portfolios can decrease your overall portfolio volatility.